search
Back to results

Prophylactic Negative Wound Pressure Therapy (PICO-7) Following Groin Incisions in Vascular Surgery (PICO-Vasc Study) (PICO-Vasc)

Primary Purpose

Surgical Wound Infection

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Regular waterproof sterile dressing.
Prophylactic Negative Pressure Dressing
Sponsored by
Corporacion Parc Tauli
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Surgical Wound Infection focused on measuring Surgical Wound Infection, Seroma, Hematoma, Lymphorrhagia, Lymphocele, Extended Hospital Admission, Postoperative Mortality

Eligibility Criteria

18 Years - 95 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age: 18-90
  • Undergoing elective revascularization surgery (Rutherford clinical categories 4-6 / Fontaine III and IV) requiring a longitudinal inguinal approach (a longitudinal inguinal incision is defined as the one that runs from the inguinal ligament to the femoral bifurcation, performed with the intention of approaching the vascular bundle).
  • Surgery performed by investigator and co-investigators: Vascular Surgeons of the Vascular Surgery Department at the Parc Taulí Hospital.
  • Patients must be able to understand the study and sign the specific informed consent before surgery.

Exclusion Criteria:

  • Urgent surgery
  • Interventions in which transverse groin wounds.
  • Presence of active groin infection that prevents primary closure
  • Pediatric patients, pregnant women or patients with impaired higher functions who cannot understand the study or collaborate with its protocolized follow-up.

Sites / Locations

  • Consorcio Sanitario Parc Tauli - Hospital Universitario.Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Conventional Dressing

Prophylactic negative wound pressure dressing

Arm Description

waterproof sterile dressing OPSITE Post-Op Visible, Smith & Nephew, UK

PICO-7, Smith & Nephew, UK

Outcomes

Primary Outcome Measures

Surgical Wound Infection Rate
Number of participant with surgical wound with inflammatory signs according to the treating surgeon criteria in the first 30 days.

Secondary Outcome Measures

Surgical Wound Complications Rate
Number of participant with surgical wound complications according to medical criteria of any of the following signs: Seroma or lymphocele Surgical wound dehiscence Hematoma Lymphorrhagia To be measured in 30 days.
Seroma or lymphocele rate
Number of participant with subcutaneous non-hematic liquid collection in the surgical bed of a closed wound. Its suspicion according to medical criteria will require puncture drainage and microbiological culture in 30 days after surgery
Surgical wound dehiscence rate
Number of participant with separation of the edges of part or all of a previously sutured wound in the 30 days after surgery
Rate of Hematoma
Number of participant with blood collection organized in the surgical bed of a closed wound in the 30 days after surgery
Rate of Lymphorrhagia
Number of participant with discharge of clear fluid through a surgical wound in the 30 days after surgery
Extended hospital admission rate
Number of participant with prolonged admission of more than 14 days due to cause/s related to the inguinal surgical wound complications or the need for reoperation, as well as, hospital readmission due to problems related to the inguinal surgical wound
Postoperative mortality Rate
Rate of death in the 30 days after surgery
Surgical wound infection-related mortality Rate
Rate of mortality secondary to infection of the surgical wound or due to causes related to complications of the inguinal surgical wound.
Level of postoperative pain
Measurement of postoperative pain in the 7 days after surgery. Carried out using the visual analog scale (VAS) applied to the patient

Full Information

First Posted
March 24, 2021
Last Updated
January 3, 2023
Sponsor
Corporacion Parc Tauli
Collaborators
Kerbi Alejandro Guevara-Noriega, Sabadell, Parc Tauli, Spain, Elena Gonzalez Canas, Sabadell, Parc Tauli, Spain, Marta Camats Terre, Sabadell, Parc Tauli, Spain, Eduardo Arrea Salto, Sabadell, Parc Tauli, Spain, Antonio Giménez Gaibar, Sabadell, Parc Tauli, Spain, Marta Santos Espi, Sabadell, Parc Tauli, Spain
search

1. Study Identification

Unique Protocol Identification Number
NCT04840576
Brief Title
Prophylactic Negative Wound Pressure Therapy (PICO-7) Following Groin Incisions in Vascular Surgery (PICO-Vasc Study)
Acronym
PICO-Vasc
Official Title
Prophylactic Negative Wound Pressure Therapy (PICO-7) Following Surgery for Revascularization of Patients With Chronic Lower Limb Ischemia (PICO-Vasc Study): A Prospective Ramdomised Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 15, 2021 (Actual)
Primary Completion Date
April 15, 2023 (Anticipated)
Study Completion Date
October 15, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Corporacion Parc Tauli
Collaborators
Kerbi Alejandro Guevara-Noriega, Sabadell, Parc Tauli, Spain, Elena Gonzalez Canas, Sabadell, Parc Tauli, Spain, Marta Camats Terre, Sabadell, Parc Tauli, Spain, Eduardo Arrea Salto, Sabadell, Parc Tauli, Spain, Antonio Giménez Gaibar, Sabadell, Parc Tauli, Spain, Marta Santos Espi, Sabadell, Parc Tauli, Spain

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Comparison between waterproof sterile dressing OPSITE Post-Op Visible, Smith & Nephew, UK and PICO-7, Smith & Nephew, UK in terms of inguinal surgical wound infection and complications after lower limb revascularization.
Detailed Description
Patients will follow a preoperative preparation: Routine pre-surgical skin hygiene with soap or antiseptic agent Groin shaving with a machine Preoperative antibiotic prophylaxis with cefazolin 2 gr ev. single dose or clindamycin 900 mg ev. in case of allergy to beta-lactams 30 min before the start of the intervention. In case of prolongation of the intervention (> 4h), a second antibiotic dose will be administered Surgical field antisepsis using a sterile swab soaked in 2% chlorhexidine solution in 70% isopropyl alcohol, except for contraindications (such as potential contact with mucosa or open wounds, in which case 10% povidone-iodine solution will be used); usual sizing. At the end of the revascularization surgical procedure, the inguinal wound will be closed using 2-0 or 3-0 Vicryl subcutaneous absorbable suture (Ethicon Inc, Somerville, NJ, USA) in two independent planes and skin closure with metal staples (B / Braun Manipler® AZ). The opaque randomization result allocation envelope will then be opened and the surgical area nurse will cover the wound with one of the two assigned dressings: Group 1 (intervention group): The surgical wound will be covered in a sterile manner with prophylactic TPN (PICO-7, Smith & Nephew, UK). Group 2 (control group): The surgical wound will be covered in a sterile way with the usual dressing (waterproof sterile dressing OPSITE Post-Op Visible, Smith & Nephew, UK). During admission, regular follow-up will be carried out. On the 7th day, the dressings of both groups will be lifted. From this moment, if the wound allows it, air healing will be carried out without new dressings. After discharge from the hospital, the surgical wound evaluation will be carried out by the nurse responsible for Outpatient Consultations at 14 and 30 days postoperatively.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgical Wound Infection
Keywords
Surgical Wound Infection, Seroma, Hematoma, Lymphorrhagia, Lymphocele, Extended Hospital Admission, Postoperative Mortality

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
2 parallel groups receiving different interventions
Masking
Participant
Masking Description
Once it is confirmed that the patient meets the inclusion criteria, exclusion criteria have been ruled out and after signing the corresponding informed consent, randomization will be carried out. The randomization will be carried out by the research center, and the assignment will be made through opaque envelopes. The assignment of the intervention group will be made by the nursing staff of the surgical area. In cases where a bilateral inguinal approach coexists in the same surgical procedure, the right side will be randomized; the contralateral incision will receive alternative therapy by default.
Allocation
Randomized
Enrollment
132 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Conventional Dressing
Arm Type
Placebo Comparator
Arm Description
waterproof sterile dressing OPSITE Post-Op Visible, Smith & Nephew, UK
Arm Title
Prophylactic negative wound pressure dressing
Arm Type
Experimental
Arm Description
PICO-7, Smith & Nephew, UK
Intervention Type
Other
Intervention Name(s)
Regular waterproof sterile dressing.
Intervention Description
Waterproof sterile dressing OPSITE Post-Op Visible, Smith & Nephew, UK
Intervention Type
Other
Intervention Name(s)
Prophylactic Negative Pressure Dressing
Intervention Description
Negative wound pressure dressing: PICO-7, Smith & Nephew, UK
Primary Outcome Measure Information:
Title
Surgical Wound Infection Rate
Description
Number of participant with surgical wound with inflammatory signs according to the treating surgeon criteria in the first 30 days.
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Surgical Wound Complications Rate
Description
Number of participant with surgical wound complications according to medical criteria of any of the following signs: Seroma or lymphocele Surgical wound dehiscence Hematoma Lymphorrhagia To be measured in 30 days.
Time Frame
30 days
Title
Seroma or lymphocele rate
Description
Number of participant with subcutaneous non-hematic liquid collection in the surgical bed of a closed wound. Its suspicion according to medical criteria will require puncture drainage and microbiological culture in 30 days after surgery
Time Frame
30 days
Title
Surgical wound dehiscence rate
Description
Number of participant with separation of the edges of part or all of a previously sutured wound in the 30 days after surgery
Time Frame
30 days
Title
Rate of Hematoma
Description
Number of participant with blood collection organized in the surgical bed of a closed wound in the 30 days after surgery
Time Frame
30 days
Title
Rate of Lymphorrhagia
Description
Number of participant with discharge of clear fluid through a surgical wound in the 30 days after surgery
Time Frame
30 days
Title
Extended hospital admission rate
Description
Number of participant with prolonged admission of more than 14 days due to cause/s related to the inguinal surgical wound complications or the need for reoperation, as well as, hospital readmission due to problems related to the inguinal surgical wound
Time Frame
30 days
Title
Postoperative mortality Rate
Description
Rate of death in the 30 days after surgery
Time Frame
30 days
Title
Surgical wound infection-related mortality Rate
Description
Rate of mortality secondary to infection of the surgical wound or due to causes related to complications of the inguinal surgical wound.
Time Frame
30 days
Title
Level of postoperative pain
Description
Measurement of postoperative pain in the 7 days after surgery. Carried out using the visual analog scale (VAS) applied to the patient
Time Frame
7 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age: 18-90 Undergoing elective revascularization surgery (Rutherford clinical categories 4-6 / Fontaine III and IV) requiring a longitudinal inguinal approach (a longitudinal inguinal incision is defined as the one that runs from the inguinal ligament to the femoral bifurcation, performed with the intention of approaching the vascular bundle). Surgery performed by investigator and co-investigators: Vascular Surgeons of the Vascular Surgery Department at the Parc Taulí Hospital. Patients must be able to understand the study and sign the specific informed consent before surgery. Exclusion Criteria: Urgent surgery Interventions in which transverse groin wounds. Presence of active groin infection that prevents primary closure Pediatric patients, pregnant women or patients with impaired higher functions who cannot understand the study or collaborate with its protocolized follow-up.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laura M Rodriguez, MD
Phone
0034629056699
Email
lmrodriguez@tauli.cat
First Name & Middle Initial & Last Name or Official Title & Degree
Kerbi A Guevara Noriega, MD MSc PhD
Phone
0034628888896
Email
kaguevara@tauli.cat
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kerbi A Guevara Noriega, MD MSc PhD
Organizational Affiliation
Vascular and Endovascular Surgery
Official's Role
Study Chair
Facility Information:
Facility Name
Consorcio Sanitario Parc Tauli - Hospital Universitario.
City
Sabadell
State/Province
Barcelona
ZIP/Postal Code
08208
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elena Gonzalez Canas, MD PhD
Phone
0034610755432
Email
egonzalez@tauli.cat
First Name & Middle Initial & Last Name & Degree
Antonio Gimenez Gaibar, MD PhD
Phone
0034629083817
Email
agimenezg@tauli.cat

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Prophylactic Negative Wound Pressure Therapy (PICO-7) Following Groin Incisions in Vascular Surgery (PICO-Vasc Study)

We'll reach out to this number within 24 hrs